We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...

“They will now charge Americans a 500% tariff for Ozempic.” The Instagram post ... USA TODAY is a verified signatory of the International Fact-Checking Network, which requires a demonstrated ...

“They will now charge Americans a 500% tariff for Ozempic.” The Instagram post received more than 100 likes in five days. The X post was reposted thousands of times, and a version of the claim also ...

Some people who use semaglutide (Ozempic, others) have noted sagging skin in the buttocks, calling it “Ozempic butt.” While lifestyle modifications may help prevent this weight loss side ...

Wed, February 5, 2025 at 9:39 PM UTC ...

Shamoon has joined the wave of people who are taking limited amounts not of psychedelics — to which the microdosing trend usually applies — but of the diabetes drug Ozempic (semaglutide), and ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite earlier hopes, a rigorous 96-week trial with 194 participants found no ...

Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said on Wednesday its net profit jumped 21 per cent in 2024 to 100 billion Danish ...